ES2123595T3 - Formas de dosis unitarias farmaceuticas topicas semi-solidas para la terapia percutanea. - Google Patents

Formas de dosis unitarias farmaceuticas topicas semi-solidas para la terapia percutanea.

Info

Publication number
ES2123595T3
ES2123595T3 ES93110690T ES93110690T ES2123595T3 ES 2123595 T3 ES2123595 T3 ES 2123595T3 ES 93110690 T ES93110690 T ES 93110690T ES 93110690 T ES93110690 T ES 93110690T ES 2123595 T3 ES2123595 T3 ES 2123595T3
Authority
ES
Spain
Prior art keywords
topic
doses
forms
applicable
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93110690T
Other languages
English (en)
Inventor
Rainer K Dr Liedtke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APL American Pharmed Labs Inc
Original Assignee
APL American Pharmed Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by APL American Pharmed Labs Inc filed Critical APL American Pharmed Labs Inc
Application granted granted Critical
Publication of ES2123595T3 publication Critical patent/ES2123595T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
    • B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2575/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D2575/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by association or interconnecting two or more sheets or blanks
    • B65D2575/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D2575/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D2575/3209—Details
    • B65D2575/3218—Details with special means for gaining access to the contents
    • B65D2575/3245—Details with special means for gaining access to the contents by peeling off the non-rigid sheet

Abstract

PARA MEJORAR LA ACTIVIDAD Y LA TOLERABILIDAD DE APLICACIONES TOXICAS USUALES PARA FORMAS MEDICINALES ACTUANDO SISTEMATICAMENTE Y TRANSDERMALMENTE SE TOMAN DE FORMAS MEDICINALES SEMISOLIDAS APROPIADAS LAS FORMAS MEDICINALES TOPICAS INDIVIDUALMENTE DOSIFICADAS QUE SON DE HECHO DE EXACTA APLICACION TERAPEUTICA. LAS DOSIS INDIVIDUALES TOPICAS SON ESPECIFICAMENTE FARMACEUTICAS RESPECTO A LAS DOSIS, RELACIONES DE APERTURA TOPICAS Y PROPIEDADES DE PERMEABILIDAD. VARIAS DOSIS INDIVIDUALES DE HECHO APLICABLES TOPICAMENTE SON UBICADAS EN UNOS RECEPTACULOS . SOPORTE TECNICOS GENERALES. MEDIANTE DOSIFICACIONES INDIVIDUALES DIFERENTES O TAMBIEN COMBINACIONES DE SUBSTANCIAS ACTIVAS SON CONFIGURABLES TERAPIAS DIFERENTES. COMO SUBSTANCIA ACTIVA FARMACOLOGICA SE EMPLEA PARTICULARMENTE ESTEROIDES, PEPTIDOS, ANALGESICOS DIFERENTES, ANESTESICOS LOCALES Y ANTIREUMATICO NO ESTEROIDAL. LA FORMA MEDICINAL TOPICA DOSIFICADA INDIVIDUALMENTE ES UN FORMA DE APLICACION SEGURA CON BUENOS COSTES Y FACTIBLE APLICABLE QUEPOSIBILITA UNA TERAPIA TOPICA EXACTA PARA LA APLICACION SISTEMATICA COMO LA LOGRABLE HASTA AHORA CON FORMAS DE APLICACION CONVENCIONAL.
ES93110690T 1992-07-13 1993-07-05 Formas de dosis unitarias farmaceuticas topicas semi-solidas para la terapia percutanea. Expired - Lifetime ES2123595T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4223004A DE4223004A1 (de) 1992-07-13 1992-07-13 Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie

Publications (1)

Publication Number Publication Date
ES2123595T3 true ES2123595T3 (es) 1999-01-16

Family

ID=6463091

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93110690T Expired - Lifetime ES2123595T3 (es) 1992-07-13 1993-07-05 Formas de dosis unitarias farmaceuticas topicas semi-solidas para la terapia percutanea.

Country Status (7)

Country Link
US (1) US5686112A (es)
EP (1) EP0581057B1 (es)
JP (1) JPH07275321A (es)
AT (1) ATE171868T1 (es)
DE (2) DE4223004A1 (es)
DK (1) DK0581057T3 (es)
ES (1) ES2123595T3 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736520A1 (de) * 1997-08-22 1999-02-25 Lohmann Therapie Syst Lts Kennzeichnung für klebende flächenförmige dermale und transdermale therapeutische Darreichungsformen unter Verwendung eines klebenden Plfasters als Informationsträger, sowie Verfahren zu seiner Herstellung
DE19746191C2 (de) * 1997-10-18 2000-05-18 Lohmann Therapie Syst Lts Verfahren zur Anwendung eines Wirkstoff enthaltenden Pflasters zur Bekämpfung oder Linderung einer Sucht
US6398753B2 (en) 1998-04-03 2002-06-04 Mcdaniel David H. Ultrasound enhancement of percutaneous drug absorption
US6030374A (en) * 1998-05-29 2000-02-29 Mcdaniel; David H. Ultrasound enhancement of percutaneous drug absorption
US7004933B2 (en) * 1998-05-29 2006-02-28 Light Bioscience L.L.C. Ultrasound enhancement of percutaneous drug absorption
DE19831263A1 (de) * 1998-07-11 2000-01-13 Lohmann Therapie Syst Lts Darreichungsform
GB9824159D0 (en) * 1998-11-04 1998-12-30 Venalink Ltd Medicine packs
US6887260B1 (en) * 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US6936044B2 (en) * 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US20060212025A1 (en) * 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US6283956B1 (en) 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
DE19900645C2 (de) * 1999-01-11 2003-03-20 Deotexis Inc Transdermales therapeutisches System
DE19911799A1 (de) 1999-03-17 2000-09-28 Lohmann Therapie Syst Lts Sammelpackung zur Entnahme von befüllten Beuteln in vorgebener Reihenfolge
JP4774179B2 (ja) * 1999-12-27 2011-09-14 帝國製薬株式会社 外用貼付剤
AU2001257326A1 (en) 2000-04-28 2001-11-12 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7820688B2 (en) * 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10213772A1 (de) * 2002-03-27 2003-10-09 Gruenenthal Gmbh Zusammenhängende Einheit aus vereinzelbaren transdermalen therapeutischen Systemen
WO2004078092A2 (en) * 2003-02-28 2004-09-16 Waikiwi Corporation Cream dispenser
WO2004092335A2 (en) 2003-04-10 2004-10-28 Light Bioscience, Inc. Photomodulation methods and devices for regulating cell proliferation and gene expression
EP1648385B1 (en) * 2003-07-31 2016-05-04 Gentlewaves Llc System and method for the photodynamic treatment of skin
JP2007503418A (ja) * 2003-08-27 2007-02-22 バイヤースドルフ・アクチエンゲゼルシヤフト 局所使用中に個別には感知不能になる外皮を有するカプセル
DE10357640A1 (de) * 2003-08-27 2005-03-24 Beiersdorf Ag Kosmetische kugelförmige Zubereitungen zur topischen Anwendung
WO2005020949A1 (de) * 2003-08-27 2005-03-10 Beiersdorf Ag Kosmetische kugelförmige zubereitungen zur topischen anwendung
DE102004045599A1 (de) * 2004-09-17 2006-03-23 Grünenthal GmbH System zur sequentiellen, transdermalen Verabreichung von systemisch wirksamen Substanzen
GB2429696A (en) * 2005-09-02 2007-03-07 Paolo Imbimbo Pharmaceutical packaging
DE202005014347U1 (de) * 2005-09-09 2007-01-18 Grünenthal GmbH Applikationssystem für ein wirkstoffhaltiges Pflaster und Wirkstoffabgaberegulierungsmittel
PL2450041T3 (pl) 2005-10-12 2019-02-28 Unimed Pharmaceuticals, Llc Ulepszony żel zawierający testosteron do zastosowania do leczenia hipogonadyzmu
DE102006011340A1 (de) * 2006-03-09 2007-09-20 Grünenthal GmbH Wirkstoffhaltige Pflaster mit verbesserter Handhabung
DE102007006244B4 (de) 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
CN103491778B (zh) 2010-04-13 2017-05-31 雷尔玛达治疗股份有限公司 1‑甲基‑n‑(2，6‑二甲苯基)‑2‑哌啶甲酰胺的皮肤用药物组合物及其使用方法
US10265283B2 (en) 2012-12-07 2019-04-23 Sambria Pharmaceuticals, Llc Topical composition and delivery system and its use
WO2016049519A1 (en) * 2014-09-25 2016-03-31 Foppe Arnold J Combination dispensing systems
WO2020190911A1 (en) * 2019-03-18 2020-09-24 Nestle Skin Health S.A. Pharmaceutical packaging system and method of manufacturing same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2194144B (en) * 1986-08-22 1990-04-25 American Cyanamid Co Stable pharmaceutical gel preparation
US4927687A (en) * 1984-10-01 1990-05-22 Biotek, Inc. Sustained release transdermal drug delivery composition
GB8622698D0 (en) * 1986-09-20 1986-10-29 Smith & Nephew Ass Dispenser
FR2609566B1 (fr) * 1987-01-14 1990-04-13 Armine Procede de determination de la trajectoire d'un corps apte a se deplacer sur une voie et dispositif de mise en oeuvre du procede
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5232703A (en) * 1989-07-21 1993-08-03 Izhak Blank Estradiol compositions and methods for topical application
US5096715A (en) * 1989-11-20 1992-03-17 Alko Ltd. Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist

Also Published As

Publication number Publication date
EP0581057B1 (de) 1998-10-07
JPH07275321A (ja) 1995-10-24
DK0581057T3 (da) 1999-06-21
ATE171868T1 (de) 1998-10-15
EP0581057A1 (de) 1994-02-02
US5686112A (en) 1997-11-11
DE4223004A1 (de) 1994-01-20
DE59309037D1 (de) 1998-11-12

Similar Documents

Publication Publication Date Title
ES2123595T3 (es) Formas de dosis unitarias farmaceuticas topicas semi-solidas para la terapia percutanea.
ES2194308T3 (es) Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.
ES2125380T3 (es) Dispositivo medico para la administracion de ingredientes activos o medicamentos a dosis muy bajas, en especial medicamentos homeopaticos.
AR014126A1 (es) Uso de una sal soluble de bismuto, un primer antibiotico y un segundo antibiotico y una forma de dosificacion faramaceutica
ES2060593T3 (es) Sistema de aporte de farmacos.
DE69923200D1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
ES2185817T3 (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de las bombas de protones y un agente antiacido o alginato.
ES2176436T3 (es) Nueva forma de dosificacion farmaceutica oral.
ATE277596T1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
DK372786D0 (da) Farmaceutiske praeparater af phenindamin
AR020830A1 (es) Formulacion liquida almacenable con formoterol
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
ES2170821T3 (es) Aplicacion topica de anestesicos locales para tratar las cefalalgias.
ES2195638T3 (es) Preparaciones de combinaciones farmaceuticas en forma solida de dosificacion que contienen cardevilol e hidroclorotiazida.
CA2245890A1 (en) Use of an extract of cimicifuga racemosa
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
UY24063A1 (es) Empleo de concentrados con contenido de factor von willebrand (vwf) como terapia de combinacion en la terapia con antitromboticos y fibrinoliticos
DE69705110T2 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
SE9803272D0 (sv) A drug for cell regeneration
AR012638A1 (es) Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional
AR042308A1 (es) Medicamento de administracion transdermica y transmucosica con absorcion mejorada de principios activos
BR0110989A (pt) Derivados de 2-aminotetralina opticamente ativos, os processos para a preparação deles e uso terapêutico de composições farmacêuticas que os contêm
ATE257377T1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
BR9910318A (pt) Uso de uma oxazolidinona e seus sais farmaceuticamente aceitáveis para a fabricação de um medicamento

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 581057

Country of ref document: ES